Biori
EN
产品中心
Your current location : Home >> Products >> Biopharmaceuticals > mRNA Raw Materials > mRNA Modification >
​Vaccinia Capping Enzyme

​Vaccinia Capping Enzyme

  • Item number:BP-E05
  • Overview
  • experimental

The capped structure at the 5' of mature mRNA, known as the m7GPPPN structure or methylguanosine cap, not only protects mRNA from RNase degradation and prolongs its half-life but also enhances its stability during translation, splicing, and nuclear export processes. The Vaccinia capping enzyme (VCE) developed by Biori integrates the necessary activities of mRNA triphosphatase, guanylyltransferase, and guanine-N7 methyltransferase, using S-adenosylmethionine (SAM) as the methyl donor. It directly adds the m7G cap structure to the 5' of mRNA. This cap structure is closely related to the stability, transport, and translation of mRNA, significantly improving the stability and translational efficiency of mRNA used for cellular validation and in vivo expression.


Product Spec.:

10 U/μL


image.png

image.png


image.png




Previous:None
Next:2-O-Methyltransferase2024-09-12
Contact Us

+86-756-8699969

Addr.: #333, Pingbei First Road, Nanping Industrial Park, Zhuhai, China 519000

Email:marketing@biori.com

 


 


 


 


Site Navigation

About Us          Cooperate Culture          Milestone

Honors         Product          Company News

Industry Highlights         Employee Spotlight          Download

Contact       


Sitemap | copyright@2021 Zhuhai Biori Biotechnology Co.,Ltd. 粤ICP备19103206号